zaltoprofen
Small moleculeexperimental
Zaltoprofen is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent. It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01369238)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2- Mol. weight
- 298.36 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaZaltoprofen ↗
- ChEMBLCHEMBL1765291 ↗
Also known as
- soleton
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofen
- zaltoprofene
- zaltoprofene
- zaltoprofeno
- zaltoprofeno
- zaltoprofenum
- zaltoprofenum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01369238 | N/A | Jun 1, 2011 | Korean Pharmacoacupuncture Institute, Kyung Hee University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Korean Pharmacoacupuncture Institute | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Kyung Hee University | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1